Agomelatine in Depressed Patients With Fibromyalgia
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Depression and unrefreshed sleep are frequent in patients with fibromyalgia. Agomelatine is a
new antidepressant with sleep-promoting properties. The objective of this study include the
assessment of agomelatine therapy in patients with depression and fibromyalgia both on the
severity of depressive symptomatology and sleep quality.